Thursday, May 10, 2012

Gene Therapy - Table of Contents alert Volume 19 Issue 5

TABLE OF CONTENTS

Volume 19, Issue 5 (May 2012)

In this issue
Enabling Technologies
Original Articles
Short Communication
Corrigendum

Also new
AOP

Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe
Advertisement
Nature Genetics and the Wellcome Trust present:
The Genomics of Common Diseases 2012
September 19-22, 2012 - Potomac, MD, USA

For more information and to register, visit:
www.nature.com/natureconferences/gcd2012
Abstract submission deadline- June 28, 2012
 

Enabling Technologies

Top

Mitochondrial gene replacement in human pluripotent stem cell-derived neural progenitors

S Iyer, E Xiao, K Alsayegh, N Eroshenko, M J Riggs, J P Bennett, Jr and R R Rao

Gene Ther 2012 19: 469-475; advance online publication, September 15, 2011; 10.1038/gt.2011.134

Abstract | Full Text

Original Articles

Top

Interleukin-10 expression induced by adeno-associated virus vector suppresses proteinuria in Zucker obese rats

M Ogura, M Urabe, T Akimoto, A Onishi, C Ito, T Ito, T Tsukahara, H Mizukami, A Kume, S Muto, E Kusano and K Ozawa

Gene Ther 2012 19: 476-482; advance online publication, November 24, 2011; 10.1038/gt.2011.183

Abstract | Full Text

Sustained induction of neuronal addition to the adult rat neostriatum by AAV4-delivered noggin and BDNF

A Benraiss, E Bruel-Jungerman, G Lu, A N Economides, B Davidson and S A Goldman

Gene Ther 2012 19: 483-493; advance online publication, September 15, 2011; 10.1038/gt.2011.114

Abstract | Full Text

Novel Clostridium perfringens enterotoxin suicide gene therapy for selective treatment of claudin-3- and -4-overexpressing tumors

W Walther, S Petkov, O N Kuvardina, J Aumann, D Kobelt, I Fichtner, M Lemm, J Piontek, I E Blasig, U Stein and P M Schlag

Gene Ther 2012 19: 494-503; advance online publication, October 6, 2011; 10.1038/gt.2011.136

Abstract | Full Text

DNA delivery to ‘ex vivo’ human liver segments

M J Herrero, L Sabater, G Guenechea, L Sendra, A I Montilla, R Abargues, V Navarro and S F Aliño

Gene Ther 2012 19: 504-512; advance online publication, October 13, 2011; 10.1038/gt.2011.144

Abstract | Full Text

Hypoxia-specific GM-CSF-overexpressing neural stem cells improve graft survival and functional recovery in spinal cord injury

H J Kim, J S Oh, S S An, W A Pennant, S-J Gwak, A N Kim, P K Han, D H Yoon, K N Kim and Y Ha

Gene Ther 2012 19: 513-521; advance online publication, October 20, 2011; 10.1038/gt.2011.137

Abstract | Full Text

LOX-1 abrogation reduces cardiac hypertrophy and collagen accumulation following chronic ischemia in the mouse

J Lu, X Wang, W Wang, H Muniyappa, C Hu, S Mitra, B Long, K Das and J L Mehta

Gene Ther 2012 19: 522-531; advance online publication, September 22, 2011; 10.1038/gt.2011.133

Abstract | Full Text

Suicidal gene therapy in the effective control of primary human hepatocellular carcinoma as monitored by noninvasive bioimaging

K C Sia, H Huynh, N Chinnasamy, K M Hui and P Y P Lam

Gene Ther 2012 19: 532-542; advance online publication, September 15, 2011; 10.1038/gt.2011.131

Abstract | Full Text

Dynamics of melanoma tumor therapy with vesicular stomatitis virus: explaining the variability in outcomes using mathematical modeling

D M Rommelfanger, C P Offord, J Dev, Z Bajzer, R G Vile and D Dingli

Gene Ther 2012 19: 543-549; advance online publication, September 15, 2011; 10.1038/gt.2011.132

Abstract | Full Text

Nonviral gene delivery of erythropoietin by mesenchymal stromal cells

F Scheibe, N Gladow, P Mergenthaler, A H Tucker, A Meisel, D J Prockop and J Priller

Gene Ther 2012 19: 550-560; advance online publication, September 29, 2011; 10.1038/gt.2011.139

Abstract | Full Text

Early intra-amniotic gene transfer using lentiviral vector improves skin blistering phenotype in a murine model of Herlitz junctional epidermolysis bullosa

M Endo, P W Zoltick, A Radu, J Qiujie, C Matsui, P M Marinkovich, J McGrath, K Tamai, J Uitto and A W Flake

Gene Ther 2012 19: 561-569; advance online publication, September 22, 2011; 10.1038/gt.2011.135

Abstract | Full Text

Mtb32 is a promising tuberculosis antigen for DNA vaccination in pre- and post-exposure mouse models

S-S Ahn, B-Y Jeon, K-S Kim, J-Y Kwack, E-G Lee, K-S Park, Y-C Sung and S-N Cho

Gene Ther 2012 19: 570-575; advance online publication, September 29, 2011; 10.1038/gt.2011.140

Abstract | Full Text

Short Communication

Top

Bovine AAV transcytosis inhibition by tannic acid results in functional expression of CFTR in vitro and altered biodistribution in vivo

G Di Pasquale, L Ostedgaard, D Vermeer, W D Swaim, P Karp and J A Chiorini

Gene Ther 2012 19: 576-581; advance online publication, October 20, 2011; 10.1038/gt.2011.138

Abstract | Full Text

Corrigendum

Top

Sustained induction of neuronal addition to the adult rat neostriatum by AAV4-delivered noggin and BDNF

A Benraiss, E Bruel-Jungerman, G Lu, A N Economides, B Davidson and S A Goldman

Gene Ther 2012 19: 582; advance online publication, November 10, 2011; 10.1038/gt.2011.182

Full Text

Advertisement
Pediatric Research Reviews
Highlights Cell-based therapies in 2012

Published in April 2012 as a special supplemental issue of Pediatric Research, the annual review issue highlights cell-based therapies in pediatrics. The articles in this issue examine developments in cell-based therapies used for treating neonatal/pediatric neuronal damage, hematologic diseases, chronic inflammatory diseases and cancers.

Visit www.nature.com/pr and gain access to these articles before they are published in print.
 
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: